REG - CVS Group plc - Directorate Change

CVSAnnouncement

18/06/2024 13:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240618:nRSR9147Sa&default-theme=true

RNS Number : 9147S  CVS Group plc  18 June 2024

For immediate release
 
18 June 2024

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

Directorate change

 

CVS, the UK listed veterinary group and a leading provider of veterinary
services announces that Ben Jacklin, Executive Director, has resigned.  Ben's
managerial and operational responsibilities, including the provision of
clinical guidance to the Board, have been assumed by other senior members of
the Group.

 

David Wilton, Chair, commented:

"On behalf of the board and everyone at CVS, I would like to thank Ben for his
significant contribution to CVS and wish him every success in the future."

 

 

This announcement contains inside information for the purposes of article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is
disclosed in accordance with the Company's obligations under Article 17 of
MAR.  The person responsible for making this announcement on behalf of the
Group is Richard Fairman, CEO.

 

 

CVS Group
plc
        via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)
                    +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

  Berenberg (Joint
Broker)
        +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial
PR)

Ginny Pulbrook
                                            +44 (0)7961
315 138

Geoffrey Pelham-Lane
                                       +44 (0)7733 124
226

 

   About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk) )

 

CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia.  CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.

 

The Group operates c.460 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices) and an online retail business ("Animed Direct").

 

The Group employs c.9,000 personnel, including c.2,400 veterinary surgeons and
c.3,400 nurses.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUWOURSSUNAAR